Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,173 public trials 550 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

NCT01804829

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +24 more
Locations: University of Southern California / Keck Hospital Los Angeles, California, United States

University of California San Francisco San Francisco, California, United States

University of Miami Miller School of Medicine Miami, Florida, United States

Florida Hospital Transplant Institute Orlando, Florida, United States

View all 23 locations

View Trial Details

Completed

Early Versus Delayed BCG Vaccination of HIV-exposed Infants

NCT02062580

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation

NCT00794911

Conditions: Blood-Borne Infections, Chronic HCV, Communicable Diseases, +12 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

HIV and Kidney Function Study

NCT00905151

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +20 more
Locations: Tufts Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults

NCT00603252

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site Wilrijk, Belgium

GSK Investigational Site Finsterwalde, Brandenburg, Germany

GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Geringswalde, Saxony, Germany

View Trial Details

Completed

Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

NCT00787371

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in Adolescents

NCT02134431

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: UCLA Clinical and Translational Research Center (CTRC) Los Angeles, California, United States

View Trial Details

Completed

Treatment Options for Protease Inhibitor-exposed Children

NCT01146873

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Rahima Moosa Mother and Child Hospital Johannesburg, Gauteng, South Africa

View Trial Details

Completed

Phase III PEG-Intron in HIV-infected Patients (Study P00738)

NCT00035360

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations: Not specified

View Trial Details

Completed

Sustiva Levels With Use of a Gel Capsule

NCT01087814

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions